NEVVI Medicare utilization intelligence
or

← back

Provider profile

TWEED, CAROL MD

Medical Oncology · NPI 1649219155 · ANNAPOLIS, MD

1
Groups
54
Codes · 2024
54,688
Disclosed services

TWEED, CAROL is a Medical Oncology in ANNAPOLIS, MD, a member of 1 medical group, who billed 54 distinct codes to Medicare Part B in 2024.

Groups: MARYLAND ONCOLOGY HEMATOLOGY PA (LAUREL, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

54,688
disclosed services
54
codes billed to Medicare Part B
Prior year · CY2023 21,899 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0897 Injection, denosumab, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J9395 Injection, fulvestrant, 25 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1626 Injection, granisetron hydrochloride, 100 mcg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9045 Injection, carboplatin, 50 mg
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
82784 Gammaglobulin (immune system protein) measurement
96372 Injection of drug or substance under skin or into muscle
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3490 Unclassified drugs
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
82728 Ferritin (blood protein) level
82565 Blood creatinine level
83550 Iron binding capacity
83540 Iron level
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83520 Measurement of substance using immunoassay technique
82378 Carcinoembryonic antigen (cea) protein level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7030 Infusion, normal saline solution , 1000 cc
96415 Administration of chemotherapy into vein, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
83615 Lactate dehydrogenase (enzyme) level
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
83735 Magnesium level
96360 Infusion into a vein for hydration, 31-60 minutes
96523 Irrigation of implanted venous access drug delivery device
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
96361 Infusion into a vein for hydration, each additional hour
83010 Haptoglobin (serum protein) level
36591 Collection of blood sample from implanted device
G0008 Administration of influenza virus vaccine
80048 Blood test, basic group of blood chemicals (calcium, total)
90653 Influenza vaccine, inactivated
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.